Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

UK Biobank is an on-going prospective epidemiological study that has already collected genetics, blood, lifestyle information and other data from a cohort of 500,000 subjects, to be followed over coming decades. The "UK Biobank Imaging Extension", which aims to bring back 100,000 of the cohort for multimodal neuroimaging and cardiac MRI (amongst other measures), has just been given the go-ahead. This will be by far the largest neuro/cardiac imaging study carried out to date, and will add very rich phenotyping to the project.

7T Scanner in FMRIB
7T Scanner in FMRIB

Funded primarily by the MRC and Wellcome Trust, the initial phase will involve imaging several thousand subjects in a new, dedicated imaging centre, which, once shown to be successfully running, would expand into the full £36m project, with two additional dedicated imaging centres setup at other sites across the UK. Major input is coming from researchers at Oxford, Imperial, Southampton, Queen Mary College and Aberdeen, with Prof Sir Rory Collins (CTSU, Oxford) heading the project.  FMRIB is leading the neuroimaging, determining the imaging hardware setup, imaging protocols and post-processing pipeline in consultation with the wider imaging community.  Prof Stephen Smith is leading this, along with Prof Heidi Johansen-Berg and Dr Karla Miller, as well as Prof Paul Matthews (Imperial/GSK).

For more information on Biobank UK please visit their website.

Similar stories

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Royal Academy of Engineering Research Fellowship

Dr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.

Three New Professors

Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'